Immunoglobulins and complement deposits have been demonstrated in the media and adjacent to the internal elastic lamina in some involved temporal arteries.' 2 However, it is not known whether such deposits were the result of passive deposition of immune complexes (IC) from the circulation or from the combination of specific antibodies with antigens in situ. It had been noticed while screening for ICs in sera from patients with a variety of disorders that raised IC levels were detected in sera from patients with polymyalgia rheumatica (PMR)/ giant cell arteritis (GCA). These observations prompted further investigation of circulating ICs in patients with PMR/GCA.
In this paper we present the results of estimating serum immune complexes by the polyethyleneglycol precipitation complement consumption assay (PEG-CC) in patients with PMR/GCA. We have correlated the results with an estimate of disease activity to assess whether the measurement of ICs could assume a role in diagnosis and patient management. Additional sera have been tested by 4 independent IC assays.
Materials and methods

PATIENTS AND CONTROLS
The diagnosis of PMR and GCA were according to the criteria of Jones and Hazleman.2 3 Fifty serum samples from 28 PMR/GCA patients were tested by the PEG-CC assay as part of a Accepted for publication 26 August 1980.
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screening study for IC in sera from patients with a variety of disorders.
Two hundred and thirty-four serum samples from 107 patients were examined together with the clinical details, erythrocyte sedimentation rate (ESR), C reactive protein (CRP), and complement measurements. Four or more samples were obtained from 26 of the patients. Of the 107 patients, mean age 67 years ± 7 (SD), 37 had PMR, 25 GCA, and 45 had both. Disease activity was assessed by one observer throughout. The symptoms of polymyalgia and of arteritis were separately graded 0-4 (inactivevery active). In an attempt to obtain an index of disease activity using both laboratory and clinical measurements the patients were subdivided into 4 groups A-D (Table 1) . The results of serial studies with three IC assays in 2 patients before and after treatment with prednisone are shown in Figs. 2 and 3. In one of these patients ( Fig. 2) 2 sera taken before treatment showed raised IC levels by all 3 assays. Subsequently PEG-CC and 1251-Clq binding IC levels returned to within the normal ranges, though the PEG-C4 IC levels remained raised. In the other patient (Fig. 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Determinations of complement levels show that both the total haemolytic complement and C3 values were within normal levels. Immunoglobulins were found to be raised in both the active and inactive group. In the active group more than one immunoglobulin was often raised in the same patient, and 18 out of 39 patients in all had raised immunoglobulins.
The Spearman rank correlation test was used to assess correlation between different measurements. There is no significant correlation between the levels of PEG-CC immune complexes and complement CH50 (r =-0 03, p>0 05), ESR (r = 0-11, p> 0 05), CRP (r-0 05, p>0 05) and a low negative correlation with C3 (r -0-16, p<0 05). 
Discussion
